![Novo Nordisk plots $1.3B in spending as it expands API production—and advances new oral meds | Fierce Pharma Novo Nordisk plots $1.3B in spending as it expands API production—and advances new oral meds | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1612447978/novo%20nordisk.jpg/novo%20nordisk.jpg?VersionId=mVeHXELAli6sz0ZUYVSiQ.6GzNEblJx3)
Novo Nordisk plots $1.3B in spending as it expands API production—and advances new oral meds | Fierce Pharma
![After a phase of slower growth, Novo Nordisk sees the fruits of its Wegovy and Rybelsus launches, CEO says | Fierce Pharma After a phase of slower growth, Novo Nordisk sees the fruits of its Wegovy and Rybelsus launches, CEO says | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1635953641/LarsFruegaardJorgensen.jpg/LarsFruegaardJorgensen.jpg?VersionId=X.ylOOiQkLD9N9SKVjiCKX6aeTvvx7EH)
After a phase of slower growth, Novo Nordisk sees the fruits of its Wegovy and Rybelsus launches, CEO says | Fierce Pharma
![Rwanda: Team Novo Nordisk fights for respect, diabetes education with Lozano's stage win - Eurosport Rwanda: Team Novo Nordisk fights for respect, diabetes education with Lozano's stage win - Eurosport](https://imgresizer.eurosport.com/unsafe/1200x0/filters:format(jpeg)/origin-imgresizer.eurosport.com/2018/08/11/2396309-49824955-2560-1440.jpg)
Rwanda: Team Novo Nordisk fights for respect, diabetes education with Lozano's stage win - Eurosport
![Novo Nordisk bolstered by another late-stage trial of once weekly insulin icodec (NVO) | Seeking Alpha Novo Nordisk bolstered by another late-stage trial of once weekly insulin icodec (NVO) | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1328498017/image_1328498017.jpg?io=getty-c-crop-4-3)